Home › Hidradenitis Suppurativa › Pennsylvania
Hidradenitis Suppurativa clinical trials in Pennsylvania
6 studies for Hidradenitis Suppurativa are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 6, Camp Hill
- Clinical Site 8, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07828860Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US074, Philadelphia
- Investigative Site US069, Plymouth Meeting
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Paddington Testing Co Inc, Philadelphia
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Sep 15, 2026 · NCT07049575Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Geisinger Medical Center, Danville
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Aug 6, 2026 · NCT07213973Myriad™ Augmented Soft Tissue Reconstruction Registry
- Lancaster General Hospital, Lancaster
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05243966Radiotherapy for Refractory Hidradenitis Suppurativa
- Thomas Jefferson University, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT07414550From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.